Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueTax ProvisionsTax Rate
Others
Ratios

Acadia Healthcare Company (ACHC) EBITDA (2016 - 2025)

Historic EBITDA for Acadia Healthcare Company (ACHC) over the last 16 years, with Q3 2025 value amounting to -$88.8 million.

  • Acadia Healthcare Company's EBITDA fell 55439.94% to -$88.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$353.6 million, marking a year-over-year decrease of 85132.63%. This contributed to the annual value of $50.7 million for FY2024, which is 11797.77% up from last year.
  • As of Q3 2025, Acadia Healthcare Company's EBITDA stood at -$88.8 million, which was down 55439.94% from -$84.4 million recorded in Q2 2025.
  • Over the past 5 years, Acadia Healthcare Company's EBITDA peaked at $24.7 million during Q2 2022, and registered a low of -$391.4 million during Q3 2023.
  • Its 5-year average for EBITDA is -$41.5 million, with a median of -$5.8 million in 2022.
  • Its EBITDA has fluctuated over the past 5 years, first skyrocketed by 38238.52% in 2022, then tumbled by 492730.3% in 2023.
  • Quarter analysis of 5 years shows Acadia Healthcare Company's EBITDA stood at $17.1 million in 2021, then crashed by 134.31% to -$5.8 million in 2022, then crashed by 210.14% to -$18.1 million in 2023, then tumbled by 340.28% to -$79.9 million in 2024, then decreased by 11.17% to -$88.8 million in 2025.
  • Its last three reported values are -$88.8 million in Q3 2025, -$84.4 million for Q2 2025, and -$100.5 million during Q1 2025.